Relative Strength Chart Abbisko Cayman Limited

Equities

Market Closed - Hong Kong S.E. Other stock markets 09:08:12 16/04/2026 BST			5-day change	1st Jan Change
13.55 ^HKD	+0.07%		+3.12%	+4.15%

03-31	Abbisko Cayman says irpagratinib granted orphan drug designation by EMA for hepatocellular carcinoma	RE
03-31	Abbisko Therapeutics Co., Ltd. Announces U.S. Food and Drug Administration Cleared the Investigational New Drug Application for ABSK061	CI

End-of-day quotes

		Sector	Change	5d. change	Varia. Jan 1.	1-year change	5-years change	Capi.	ST	MT	LT
	ABBISKO CAYMAN LIMITED	Bio Therapeutic Drugs	+0.07%	+3.12%	+4.15%	+89.25%	-	1.16B